Entry |
|
Name |
Naporafenib (USAN/INN) |
Formula |
C25H25F3N4O4
|
Exact mass |
502.1828
|
Mol weight |
502.48
|
Structure |

|
Class |
Antineoplastic
DG01918 Tyrosine kinase inhibitor
|
Efficacy |
Antineoplastic, Tyrosine kinase inhibitor |
Comment |
Treatment of cancer
|
Target |
|
Pathway |
|
Interaction |
|
Brite |
Drug groups [BR:br08330]
Antineoplastic
DG01918 Tyrosine kinase inhibitor
D12831 Naporafenib
Target-based classification of drugs [BR:br08310]
Protein kinases
Serine/threonine kinases
TKL group
BRAF
D12831 Naporafenib (USAN/INN)
RAF1
D12831 Naporafenib (USAN/INN)
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 36
1 O2x O 9.6029 -13.1912
2 C1x C 9.6029 -14.5946
3 C1x C 10.8182 -15.2963
4 N1y N 12.0337 -14.5946
5 C1x C 12.0337 -13.1912
6 C1x C 10.8182 -12.4896
7 C8y C 13.2677 -15.3073
8 N5x N 13.2674 -16.6995
9 C8y C 14.4826 -17.4015
10 C8x C 15.6981 -16.7001
11 C8y C 15.6984 -15.3079
12 C8x C 14.4832 -14.6059
13 C8y C 16.9258 -14.5997
14 C8x C 18.1196 -15.2896
15 C8y C 19.3352 -14.5883
16 C8x C 19.3357 -13.1849
17 C8x C 18.1420 -12.4951
18 C8y C 16.9264 -13.1964
19 N1b N 20.5688 -15.3012
20 C5a C 21.7717 -14.6072
21 C8y C 22.9590 -15.2934
22 O5a O 21.7725 -13.1915
23 C8x C 22.9585 -16.6994
24 C8x C 24.1736 -17.4015
25 N5x N 25.3892 -16.7003
26 C8y C 25.3897 -15.2942
27 C8x C 24.1746 -14.5921
28 C1d C 26.6051 -14.5930
29 X F 27.8205 -13.8913
30 X F 25.9035 -13.3777
31 X F 27.3068 -15.8084
32 O2a O 14.4823 -18.8043
33 C1b C 13.2912 -19.4920
34 C1b C 12.1050 -18.8072
35 O1a O 10.9088 -19.4979
36 C1a C 15.7389 -12.5107
BOND 39
1 1 2 1
2 2 3 1
3 3 4 1
4 4 5 1
5 5 6 1
6 1 6 1
7 4 7 1
8 7 8 2
9 8 9 1
10 9 10 2
11 10 11 1
12 11 12 2
13 7 12 1
14 11 13 1
15 13 14 2
16 14 15 1
17 15 16 2
18 16 17 1
19 17 18 2
20 13 18 1
21 15 19 1
22 19 20 1
23 20 21 1
24 20 22 2
25 21 23 2
26 23 24 1
27 24 25 2
28 25 26 1
29 26 27 2
30 21 27 1
31 26 28 1
32 28 29 1
33 28 30 1
34 28 31 1
35 9 32 1
36 32 33 1
37 33 34 1
38 34 35 1
39 18 36 1
|